Epidemiological Study on Mental Health of Migrant Population in the Retention Center of Geispolsheim.

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT04329936
Collaborator
(none)
30
1
12
2.5

Study Details

Study Description

Brief Summary

In 2019, the lack of studies about mental health of the detained population at retention centers in France is pointed out by the report of Controller-General for Places of Deprivation of Liberty. The aim of this study is to contribute to this relatively untouched field by describing which psychiatric pathologies are encountered in this population who went through migration and retention. Having a clearer picture of the situation can help to provide a more adapted psychiatric care in retention centers.

The results are expected to show a higher rate of psychiatric disease than in the general population including addiction to substance, anxiety disorder and post-traumatic stress disorder (PTSD).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Retention center Geispolsheim population

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Epidemiological Study on Mental Health of Migrant Population in the Retention Center of Geispolsheim
Anticipated Study Start Date :
May 1, 2020
Anticipated Primary Completion Date :
May 1, 2020
Anticipated Study Completion Date :
May 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Mini International Neuropsychiatric Interview validated and translated in the language used by the interviewed person. [1 hour]

    The interview is led by the investigator in the presence of a translator if necessary.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Any male person in the first week of detention at CRA Geispolsheim who gave their non-opposition to participation in the study.

  • Information and consent protocol signed

Exclusion Criteria:
  • Refuse to participate to the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Les Hôpitaux Universitaires de Strasbourg Strasbourg France 67091

Sponsors and Collaborators

  • University Hospital, Strasbourg, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT04329936
Other Study ID Numbers:
  • 7657
First Posted:
Apr 1, 2020
Last Update Posted:
Apr 1, 2020
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Strasbourg, France

Study Results

No Results Posted as of Apr 1, 2020